Lumida
/PIPR
⌘K
Piper Sandler Companies

Piper Sandler Companies

PIPR
$76.32USD↓-1.73%-1.34 today

MARKET CAP

5.4B

P/E (TTM)

17.3x

FWD P/E

14.2x

DAY RANGE

$75 – $78

52W RANGE

$69
$95

AI Summary

Stalk
TrimMedium

PIPR is in Stage 3 distribution within a longer-term uptrend. The medium-term bias is bearish, reinforced by a Lower Highs & Lower Lows pattern, underperformance versus the market, and repeated failures near the sloping 9/21 EMA zone. Short-term timing is neutral as price approaches these EMAs without clear rejection or exhaustion. Execution should be deferred into rallies toward the 9/21 EMA resistance (and near the 50 DMA) for trimming on signs of supply at resistance.

  • ↑Q1 2026 adjusted net revenues $470M, up 22% YoY
  • ↑Advisory services hit $251M in Q1 (+16% YoY), strongest on record
  • ↓Corporate financing revenues plunged to $36M in Q1, down 32% YoY
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Piper Sandler Companies (NYSE: PIPR) is a prominent investment banking and asset management firm specializing in advisory services, capital markets, and institutional brokerage. The company focuses on a diverse client base, encompassing corporations, financial institutions, and private equity sponsors, primarily within sectors like healthcare and financial services. Piper Sandler continues to navigate through evolving market landscapes, capitalizing on opportunities and deep sector expertise to maintain its competitive positioning.

Bull says

  • ↑Q1 2026 adjusted net revenues $470M, up 22% YoY
  • ↑Advisory services hit $251M in Q1 (+16% YoY), strongest on record
  • ↑Returned $171M to shareholders in Q1 via buybacks & 14% higher $0.20/share dividend
  • ↑Operating margin steady at 20%, reflecting disciplined cost management
  • ↑Added senior hires to expand healthcare franchise and deepen client engagements
  • ↑High earnings yield and positive momentum signal attractive valuation for investors

Bear says

  • ↓Corporate financing revenues plunged to $36M in Q1, down 32% YoY
  • ↓Signs of slowing top-line growth raise risk of downward earnings revisions
  • ↓Elevated short interest and falling institutional holdings signal investor skepticism
  • ↓Persistent market volatility could hamper deal timing and advisory momentum
  • ↓Negative profitability trends may pressure future margins despite current 20% level
  • ↓AI-driven disruption and rising competition pose a threat to traditional advisory moat

Investment themes with PIPR

High Dividend Yield↑ +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM
Capital Markets↓ -0.02%

Debt and equity trading fueling economic growth

SNEX · AAMI · PWP
Brokerages↓ -0.12%

GS · MS · SCHW

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-02-2026neutral

Transcript signals

Bull points

  • We posted a strong start to the year, generating first quarter adjusted net revenues of $470 million, our 10th consecutive quarter of year-over-year growth, a 20% operating margin, and adjusted EPS of $1.
  • Corporate investment banking achieved a first quarter record with revenues of $324 million, up 30% year-over-year due to robust corporate financing activity as well as solid contributions across advisory services.
  • Advisory revenues were a first quarter record of $251 million, up 16% year-over-year due to the strong performance from healthcare and financial services and contributions from our services and industrials and energy teams.

Bear points

  • we expect second quarter corporate financing revenues to decline from a strong first quarter.
  • We generated $24 million of municipal financing revenues for the quarter, down 9% year over year.
  • We expect our second quarter revenues to decline from the record first quarter levels.
Read full transcript analysis ›